Outcome of peptic ulcer bleeding among users of traditional non-steroidal anti-inflammatory drugs and selective cyclo-oxygenase-2 inhibitors
about
Why do mortality rates for nonvariceal upper gastrointestinal bleeding differ around the world? A systematic review of cohort studies.Chronic liver disease and 90-day mortality in 21,359 patients following peptic ulcer bleeding--a Nationwide Cohort Study.Time trends in incidence of peptic ulcer bleeding and associated risk factors in Norway 1985-2008.Preadmission use of SSRIs alone or in combination with NSAIDs and 30-day mortality after peptic ulcer bleeding.Nonsteroidal anti-inflammatory drug usage and gastrointestinal outcomes in the Republic of Serbia.
P2860
Outcome of peptic ulcer bleeding among users of traditional non-steroidal anti-inflammatory drugs and selective cyclo-oxygenase-2 inhibitors
description
im Oktober 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 10 October 2006
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2006
@uk
name
Outcome of peptic ulcer bleedi ...... e cyclo-oxygenase-2 inhibitors
@en
Outcome of peptic ulcer bleedi ...... e cyclo-oxygenase-2 inhibitors
@nl
type
label
Outcome of peptic ulcer bleedi ...... e cyclo-oxygenase-2 inhibitors
@en
Outcome of peptic ulcer bleedi ...... e cyclo-oxygenase-2 inhibitors
@nl
prefLabel
Outcome of peptic ulcer bleedi ...... e cyclo-oxygenase-2 inhibitors
@en
Outcome of peptic ulcer bleedi ...... e cyclo-oxygenase-2 inhibitors
@nl
P2093
P2860
P1476
Outcome of peptic ulcer bleedi ...... e cyclo-oxygenase-2 inhibitors
@en
P2093
Christensen S
McLaughlin JK
Sørensen HT
P2860
P304
P356
10.1111/J.1365-2036.2006.03139.X
P407
P577
2006-10-10T00:00:00Z